Schütz C - Search Results

1

The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.

Mougiakakos D, Bach C, Böttcher M, Beier F, Röhner L, Stoll A, Rehli M, Gebhard C, Lischer C, Eberhardt M, Vera J, Büttner-Herold M, Bitterer K, Balzer H, Leffler M, Jitschin S, Hundemer M, Awwad MHS, Busch M, Stenger S, Völkl S, Schütz C, Krönke J, Mackensen A, Bruns H. Mougiakakos D, et al. Among authors: schutz c. Cancer Immunol Res. 2021 Mar;9(3):265-278. doi: 10.1158/2326-6066.CIR-20-0555. Epub 2021 Feb 9. Cancer Immunol Res. 2021. PMID: 33563611

2

CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells.

Bruns H, Bessell C, Varela JC, Haupt C, Fang J, Pasemann S, Mackensen A, Oelke M, Schneck JP, Schütz C. Bruns H, et al. Among authors: schutz c. Clin Cancer Res. 2015 May 1;21(9):2075-83. doi: 10.1158/1078-0432.CCR-14-2696. Epub 2015 Jan 15. Clin Cancer Res. 2015. PMID: 25593301 Free PMC article.

3

A new flow cytometric assay for the simultaneous analysis of antigen-specific elimination of T cells in heterogeneous T cell populations.

Schütz C, Fischer K, Völkl S, Hoves S, Halbritter D, Mackensen A, Fleck M. Schütz C, et al. J Immunol Methods. 2009 May 31;344(2):98-108. doi: 10.1016/j.jim.2009.03.008. Epub 2009 Mar 28. J Immunol Methods. 2009. PMID: 19332073

4

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

Schütz C, Fleck M, Mackensen A, Zoso A, Halbritter D, Schneck JP, Oelke M. Schütz C, et al. Blood. 2008 Apr 1;111(7):3546-52. doi: 10.1182/blood-2007-09-113522. Epub 2007 Dec 20. Blood. 2008. PMID: 18096763 Free PMC article.

5

Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.

Schütz C, Oelke M, Schneck JP, Mackensen A, Fleck M. Schütz C, et al. Immunotherapy. 2010 Jul;2(4):539-50. doi: 10.2217/imt.10.26. Immunotherapy. 2010. PMID: 20636007 Free PMC article. Review.

6

Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells.

Hoves S, Krause SW, Schütz C, Halbritter D, Schölmerich J, Herfarth H, Fleck M. Hoves S, et al. Among authors: schutz c. J Immunol. 2006 Aug 15;177(4):2691-8. doi: 10.4049/jimmunol.177.4.2691. J Immunol. 2006. PMID: 16888031

7

Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells.

Schütz C, Hoves S, Halbritter D, Zhang HG, Mountz JD, Fleck M. Schütz C, et al. Immunology. 2011 May;133(1):115-22. doi: 10.1111/j.1365-2567.2011.03417.x. Epub 2011 Feb 22. Immunology. 2011. PMID: 21342185 Free PMC article.

8

The adiponectin paralog CORS-26 has anti-inflammatory properties and is produced by human monocytic cells.

Weigert J, Neumeier M, Schäffler A, Fleck M, Schölmerich J, Schütz C, Buechler C. Weigert J, et al. Among authors: schutz c. FEBS Lett. 2005 Oct 24;579(25):5565-70. doi: 10.1016/j.febslet.2005.09.022. Epub 2005 Sep 28. FEBS Lett. 2005. PMID: 16213490 Free article.

9

Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells.

Schütz C, Varela JC, Perica K, Haupt C, Oelke M, Schneck JP. Schütz C, et al. Oncotarget. 2016 Oct 18;7(42):68503-68512. doi: 10.18632/oncotarget.11785. Oncotarget. 2016. PMID: 27602488 Free PMC article.

10

Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy.

Perica K, Bieler JG, Schütz C, Varela JC, Douglass J, Skora A, Chiu YL, Oelke M, Kinzler K, Zhou S, Vogelstein B, Schneck JP. Perica K, et al. Among authors: schutz c. ACS Nano. 2015 Jul 28;9(7):6861-71. doi: 10.1021/acsnano.5b02829. Epub 2015 Jul 14. ACS Nano. 2015. PMID: 26171764 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

367 results

Search Page